2007 Neurofibromatosis Conference

描述（由申请人提供）：本申请申请为儿童肿瘤基金会国际NF会议2007年年会提供资金支持。会议将于2007年6月10日至12日在犹他州帕克城的峡谷度假村举行。自1985年成立以来，这个年度会议已经取得了丰硕的成果，它作为NF社区研究人员和临床医生的首要年度聚会发挥着关键作用。该会议是为来自世界各地的研究人员提供研究信息交流和讨论的论坛，传统上促进了合作、共识的建立和转化研究的进展，最终实现了临床试验。从基础到临床，这是NF研究在许多方面取得巨大进展的时代，这反映在2007年会议的主题——“模型、机制和治疗靶点”中。七个单独的会议将带领联盟从NF的分子机制到转化模型到临床治疗。演讲者将包括初级和高级研究人员。本次会议的目的是将生物化学、细胞和有机体系统的最新发现与临床前和临床研究结合起来。每次会议还将包括由NF研究之外的主要研究者发表主题演讲，以展开广泛的讨论。有竞争力的旅行奖将邀请年轻的研究人员进行口头报告，两个海报会议将允许研究人员向NF社区展示他们的工作。我们采取了两种新方法，以提高这次会议和NF研究状况的可见度。首先，为了提高行业对NF的认识，我们将向大量的制药公司寻求本次会议的财政赞助。奖励赞助将提供钻石，白金，金和银级别。其次，联合主席和基金会将共同努力，寻求在同行评议的期刊上发表一份联合报告。这将促进整个研究界了解NF研究的现状、与其他癌症和神经系统疾病的联系以及需要解决的主要障碍。

DESCRIPTION (provided by applicant): This application requests funding support for the 2007 annual meeting of the Children's Tumor Foundation International NF Conference. The Meeting will be held June 10-12, 2007, at the Canyons Resort in Park City, Utah. This annual meeting has had a fruitful history since its inception in 1985, and it plays a lynchpin role as the premier annual gathering of researchers and clinicians in the NF community. The meeting is a forum for research information exchange and discussion for researchers from around the world, and has traditionally fostered collaboration, consensus building, and advances in translational research culminating in clinical trials. This is a time of tremendous advances in NF research on many fronts, from basic through clinical, and this is reflected in the theme of the 2007 meeting - 'Models, Mechanisms, and Therapeutic Targets'. Seven individual sessions will take the Consortium from molecular mechanisms of NF through translational models to clinical therapies. Speakers will include both junior and senior researchers. The goal of this meeting is to juxtapose current findings in biochemical, cellular and organismal systems with preclinical and clinical studies. Each session will also include a keynote address by a leading investigator from outside of NF research to open up broad ranging discussions. Competitive travel awards will bring young investigators for oral presentations, and two poster sessions will allow investigators to present their work to the NF community. We have taken two new approaches in order to increase the visibility of this meeting and of the state of NF research. First, to increase industry awareness of NF, we will seek fiscal sponsorship for this meeting from a large number of pharmaceutical companies. Incentive sponsorships will be offered at diamond, platinum, gold and silver levels. Secondly, the co- chairs and the Foundation will work together to seek publication of a Consortium Report in a peer-reviewed journal. This will promote to the research community at large the status of NF research, the link with other cancers and neurological disorders and the key barriers to be addressed.